Trial Profile
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Linzagolix (Primary) ; Leuprorelin
- Indications Endometriosis; Pelvic pain
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 03 Jun 2019 Status changed from active, no longer recruiting to completed.
- 29 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 24 May 2016 New trial record